Harvard Medical School 

01/19/2017

Precision medicine—in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers—has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Harvard Medical School and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center suggests.

>>Read more